Drug Profile
KST 150185
Alternative Names: KST 150213Latest Information Update: 24 May 2001
Price :
$50
*
At a glance
- Originator Korea Institute of Science and Technology
- Class Antibacterials; Cephalosporins
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 24 May 2001 No-Development-Reported for Bacterial infections in South Korea (IV)
- 30 Nov 1994 Preclinical development for Bacterial infections in South Korea (IV)